19621457

Source:http://linkedlifedata.com/resource/pubmed/id/19621457

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008059, umls-concept:C0015392, umls-concept:C0017638, umls-concept:C0175860, umls-concept:C1274040, umls-concept:C1704259, umls-concept:C1705987
pubmed:issue	7
pubmed:dateCreated	2009-10-19
pubmed:abstractText	The optimal management of optic pathway gliomas (OPGs) is complicated by their variable natural history, the association with neurofibromatosis type 1 (NF1) and difficulties in defining progression and response to treatment.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101186624
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Carboplatin, http://linkedlifedata.com/resource/pubmed/chemical/Lomustine, http://linkedlifedata.com/resource/pubmed/chemical/Procarbazine, http://linkedlifedata.com/resource/pubmed/chemical/Thioguanine, http://linkedlifedata.com/resource/pubmed/chemical/Vinblastine, http://linkedlifedata.com/resource/pubmed/chemical/Vincristine
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1545-5017
pubmed:author	pubmed-author:BartelsUteU, pubmed-author:BouffetEricE, pubmed-author:BuncicJ RaymondJR, pubmed-author:HargraveDarrenD, pubmed-author:MabbottDonaldD, pubmed-author:NicolinGaryG, pubmed-author:ParkinPatriciaP, pubmed-author:RutkaJamesJ, pubmed-author:TaboriUriU
pubmed:copyrightInfo	(c) 2009 Wiley-Liss, Inc.
pubmed:issnType	Electronic
pubmed:day	15
pubmed:volume	53
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1231-7
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:19621457-Adolescent, pubmed-meshheading:19621457-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:19621457-Brain Damage, Chronic, pubmed-meshheading:19621457-Carboplatin, pubmed-meshheading:19621457-Child, pubmed-meshheading:19621457-Child, Preschool, pubmed-meshheading:19621457-Combined Modality Therapy, pubmed-meshheading:19621457-Cranial Irradiation, pubmed-meshheading:19621457-Disease Progression, pubmed-meshheading:19621457-Disease-Free Survival, pubmed-meshheading:19621457-Female, pubmed-meshheading:19621457-Follow-Up Studies, pubmed-meshheading:19621457-Humans, pubmed-meshheading:19621457-Infant, pubmed-meshheading:19621457-Intellectual Disability, pubmed-meshheading:19621457-Lomustine, pubmed-meshheading:19621457-Male, pubmed-meshheading:19621457-Neurofibromatosis 1, pubmed-meshheading:19621457-Optic Nerve Glioma, pubmed-meshheading:19621457-Procarbazine, pubmed-meshheading:19621457-Retrospective Studies, pubmed-meshheading:19621457-Survival Analysis, pubmed-meshheading:19621457-Thioguanine, pubmed-meshheading:19621457-Treatment Outcome, pubmed-meshheading:19621457-Vinblastine, pubmed-meshheading:19621457-Vincristine, pubmed-meshheading:19621457-Vision Disorders
pubmed:year	2009
pubmed:articleTitle	Natural history and outcome of optic pathway gliomas in children.
pubmed:affiliation	Pediatric Brain Tumor Program, Division of Hematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't